Aligos Therapeutics (ALGS) Depreciation and Depletion (2019 - 2026)
Aligos Therapeutics (ALGS) reported Depreciation and Depletion of $300000.0 for Q1 2026, up 50.0% on a YoY basis from $200000.0 in Q1 2025, and up 32.16% quarter-over-quarter from $227000.0 in Q4 2025.
Aligos Therapeutics (ALGS) Depreciation and Depletion (2019 - 2026) Analysis & Trends
Aligos Therapeutics has reported Depreciation and Depletion for 8 years, with the latest figure at $300000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 50.0% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 1.28% YoY), and the FY2025 full-year result was $900000.0, down 10.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $300000.0, up from $227000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $676000.0 in Q1 2022, with the low at $200000.0 in Q1 2025.
- Historically, Depreciation and Depletion has averaged $360941.2 across 5 years, with a median of $300000.0 in 2023.
- Annual changes were most pronounced in 2024 — Depreciation and Depletion tumbled 40.39% — and 2026, when it jumped 50.0%.
- Aligos Therapeutics' Depreciation and Depletion stood at $506000.0 in 2022, then slipped by 29.05% to $359000.0 in 2023, then plunged by 40.39% to $214000.0 in 2024, then increased by 6.07% to $227000.0 in 2025, then soared by 32.16% to $300000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $300000.0 (Q1 2026), $227000.0 (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Aligos Therapeutics | 51.70 Mn | -28.13 Mn | - | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 227,000.00 |
| Dec 31, 2025 | 227,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 359,000.00 |
| Dec 31, 2023 | 359,000.00 |